The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, ...

From artificial intelligence and IOL innovation to biosimilars, geographic atrophy, and postoperative eye protection, Joshua ...

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...

Currently, ophthalmology tops the list of specialties with the most ongoing clinical trials, followed by oncology, family practice, cardiology and gastroenterology. Nine fast facts on ongoing clinical ...

Please provide your email address to receive an email when new articles are posted on . ROME — The total estimated costs from inherited retinal diseases in the United States amounts to $31.8 billion.

Joseph M. Coney, MD, FACS, discusses the importance of diverse representation in clinical trials for the ongoing advancement of safe and effective treatments, and underscores the need for cultivating ...

For years, the John A. Moran Eye Center’s Clinical Ophthalmology Resource for Education (CORE) has offered worldwide access to high-quality ophthalmic learning—an important step in addressing curable ...

Ophthalmology leaders nationwide have ranked the John A. Moran Eye Center at the University of Utah as among the top 12 programs in the nation when it comes to clinical care, research, and education.

CBCC Global Research, a multi-national clinical contract research organization ("CRO") with deep experience in designing and managing clinical trials across its core therapeutic areas, including ...

As part of the transaction, iuvo has named Shannon Stoddard as president, clinical research for the combined clinical research business iuvo BioScience was founded in 2015 and Promedica was founded in ...